ProductsLang Bragman GB Axis, 30s
(2)

Write A Review

Lang Bragman GB Axis, 30s

by Attivo

Lang Bragman GB Axis is formulated with two clinically proven probiotics, Lactobacillus plantarum DR7 and Bifidobacterium breve CCFM1025, which have demonstrated benefits in supporting gut health and stress response in the body. These probiotics work through the regulation of the serotonergic system while alleviating related gastrointestinal issues.

First Order: Use code ‘welcome5’ to enjoy $5 off.

 

SGD 64.31

In Stock

Share:
SKU: 120176
Brand:
sold by: Attivo

Tags: Probiotics

Description

Highlights

  • Formulated to support healthy stress response in the body
  • Help support healthy mucous tissue of the respiratory tract
  • Induces better sleep quality

 

Active Ingredients 

Lactobacillus plantarum DR7 10 mg
Bifidobacterium breve CCFM1025 50 mg

 

Direction of Use

  • Take 1-2 capsules daily after meal.

 

Warnings

  • Space out your probiotic and antibiotic by a minimum of 4 hours to prevent them from interfering with each other.
  • Pregnant or breastfeeding women should seek healthcare professional advice before using this product.

 

Storage

Store at room temperature and avoid sun exposure.

*This complementary health product is notified with the HSA based on information submitted to the Authority. Consumer discretion is advised.

 

References

1. Chong, H. X., et al. (2019). “Lactobacillus plantarum DR7 alleviates stress and anxiety in adults: a randomised, double-blind, placebo-controlled study.” Beneficial Microbes.
2. Chong, H. X., Yusoff, N. A. A., Hor, Y. Y., Lew, L. C., Jaafar, M. H., Choi, S. B., Yusoff, M. S. B., Wahid, N., Abdullah, M. F. I. L., Zakaria, N., Ong, K. L., Park, Y. H., & Liong, M. T. (2019). Lactobacillus plantarum DR7 improved upper respiratory tract infections via enhancing immune and inflammatory parameters: A randomized, double-blind, placebo-controlled study. Journal of dairy science, 102(6), 4783–4797. https://doi.org/10.3168/jds.2018-16103
3. Dempsey, E., & Corr, S. C. (2022). Lactobacillus spp. for Gastrointestinal Health: Current and Future Perspectives. Frontiers in immunology, 13, 840245. https://doi.org/10.3389/fimmu.2022.840245

Thanks for your review!

Your feedback helps us improve our service.

error

Please log in to submit a review.

Don't have an account? Register here .

Questions & Answers

There are no questions yet. Be the first to ask a question about this product.

Only registered users are eligible to enter questions